TITLE
Renal cancer response to rapamycin analog CCI-779 treatment: time course

SUMMARY
Expression profiling of peripheral blood mononuclear cells (PBMC) from patients with advanced renal cancer following treatment with the rapamycin analog CCI-779. Gene expression examined 8 and 16 weeks after treatment. Results identify potential gene markers of CCI-779 exposure.

ORGANISM
Homo sapiens

